Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Medrio
company
About
Medrio provides advanced electronic data capture (EDC) and e-clinical tools suitable for complex clinical trials.
- 51 - 100
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- $2.02M
- Industries
- Health Care,SaaS,Software
- Founded date
- Jan 1, 2005
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Medrio provides advanced Electronic Data Capture (EDC) and eClinical tools suitable for the most complex clinical trials but built on a platform that makes us faster, lower in cost, and more streamlined than the competition. Since 2005 Medrio has been building a true Software as a Service (SaaS) solution for data management in clinical trials. Based in San Francisco, California, Medrio puts the control in your hands with our smart, forward thinking eClinical offering.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$2.02M
Medrio has raised a total of
$2.02M
in funding over 2 rounds. Their latest funding was raised on
Oct 31, 2011 from a Series Unknown round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 31, 2011 | Series Unknown | $2.02M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Medrio is funded by 1 investors.
Think + Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Think + Ventures
|
— | Series Unknown |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
